Loading clinical trials...
Loading clinical trials...
The purpose of this trial is to determine whether Application (APP) would help clinical doctors to adjust the dose of Oxycodone Hydrochloride Prolonged-release Tablets in advanced patients with cancer pain.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
Start Date
January 1, 2017
Primary Completion Date
December 1, 2019
Completion Date
December 1, 2019
Last Updated
January 23, 2019
200
ESTIMATED participants
APP software
DEVICE
Lead Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
NCT06346132
NCT07482709
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07351968